Immunohistochemical analysis of Ki67 demonstrated significantly decreased proliferative activity in the sh-LRRC75A-AS1 group, consistent with reduced tumor growth, and again, this effect was mitigated by miR-489-3p inhibition and re-suppressed upon ARD1 silencing (Fig. 5D). This evidence concerns the gene MKI67 and neoplasm.